See also this year's filing and all EDGAR filings for this company.
PDF Report 0001366541_2012_Q_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001366541, Q Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,795,315 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 31,923 |
| 3 | remainder_Assets | 7,513 |
| 4 | LiabilitiesCurrent | 293,794 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,567,012 |
| 9 | ResearchAndDevelopmentExpense | 444,834 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 174,573 |
| 12 | remainder_NetIncome | -762,065 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,834,751 |
| 1 | Liabilities | 293,794 |
| 2 | Expenses | 2,011,846 |
| 3 | Revenues | 174,573 |
| 4 | StockholdersEquity | 2,540,957 |
| 5 | NetIncome | -2,599,338 |
| 6 | ComprehensiveNetIncome | -2,599,338 |
| 7 | BaseVar | 3,038,514 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.88 |
| 9 | EconomicCapitalRatio | 2.94 |
Edgar->Model Mapping
Feature Distribution
